Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC12577 | AC-263093 Featured |
AC-263093 (AC263093) is a potent, functionally selective neuropeptide FF receptor type 2 (NPFFR2) agonist with pKi of 6.9.
More description
|
![]() |
DC12492 | N-(p-Amylcinnamoyl) anthranilic Acid (ACA) Featured |
ACA is a cell permeable inhibitor of PLA2,reported to inhibit α-ketoisocaproic acid and glyceraldehyde-induced insulin secretion, as well as glucose-induced insulin secretion.
More description
|
![]() |
DC9917 | Acacetin Featured |
Acacetin is an O-methylated flavone found in Robinia pseudoacacia (black locust), Turnera diffusa (damiana),Betula pendula (silver birch),and in the fern Asplenium normale.
More description
|
![]() |
DC22280 | Acarbose Featured |
Acarbose is the first identified α-glucosidase inhibitor.
More description
|
![]() |
DC9986 | Acebilustat(ZK322) Featured |
Acebilustat(ZK322) is a potent and selective leukotriene A4 hydrolase inhibitor.
More description
|
![]() |
DC10592 | ASL 601(Acecainide) Featured |
Acecainide, also known as N-acetylprocainamide and ASL 601, is the N-acetylated metabolite of procainamide.
More description
|
![]() |
DC10492 | ACSS2 inhibitor Featured |
ACSS2 inhibitor is a novel ACSS2 inhibitor.
More description
|
![]() |
DC7997 | ACTB-1003 Featured |
ACTB-1003 is a potent inhibitor of FGFR1 with IC50 <10 nM in FGFR-1 biochemical assay; more information can be find in Patent WO/2007/064883A2, Example 12.
More description
|
![]() |
DC10745 | Adelmidrol Featured |
Adelmidrol is an anti-inflammatory ethanolamide derivative of azelaic acid.
More description
|
![]() |
DC8355 | Adjudin (AF-2364) Featured |
AF-2364, an analogue of Lonidamine (LND), had a contraceptive effect when orally administered to adult Sprague–Dawley rats.
More description
|
![]() |
DC10623 | AG-494 Featured |
AG-494 is an inhibitor of epidermal growth factor receptor kinase with an IC50 value of 1 µM in HT-22 cells.
More description
|
![]() |
DC9338 | ALK inhibitor 1 Featured |
ALK inhibitor 1 is a novel and selective inhibitor for the ALK kinase.
More description
|
![]() |
DC9339 | ALK inhibitor 2 Featured |
ALK inhibitor 2 is a novel and selective inhibitor for the ALK kinase.
More description
|
![]() |
DC10582 | Diroximel Fumarete(ALKS-8700) Featured |
ALKS-8700 also known as diroximel fumarate, is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body.
More description
|
![]() |
DC5076 | Alogliptin Benzoate Featured |
Alogliptin is an orally administered, anti-diabetic drug in the DPP-4 inhibitor class. A randomized clinical trial reporting in 2011 aimed to determine the efficacy and safety of alogliptin versus placebo and voglibose among newly diagnosed Type 2 diabete
More description
|
![]() |
DC10735 | Alovudine Featured |
Alovudine is a DNA polymerase subunit gamma-1 (POLG) inhibitor, shows promise for treating AML.
More description
|
![]() |
DC9920 | alpha-Hederin Featured |
alpha-hederin is a water-soluble pentacyclic triterpenoid saponin, possessing several biological properties such as antispasmodic, moliscicidic, anthelmithic and inhibiting cell proliferation.
More description
|
![]() |
DC23079 | α-mangostin Featured |
Alpha-Mangostin has neuroprotective, anti-cancer, antifungal, neuroprotective, renoprotective, antioxidant and anti-inflammatory activities.
More description
|
![]() |
DC26001 | Alprenolol Featured |
Alprenolol is a non-selective beta blocker as well as 5-HT1A receptor antagonist.
More description
|
![]() |
DC12656 | Alrestatin Featured |
Alrestatin is an AKR (aldose reductase) inhibitor, which attaches molecules to the active site of the NADP+/enzyme complex in a stacked formation.
More description
|
![]() |
DC21483 | PF03715455 Featured |
PF-03715455 is a potent inhaled p38 MAPK inhibitor. PF-03715455 shows some selectivity for p38α over p38β with respective IC50 values of 0.88 and 23 nM. PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 has potential for the treatment of COPD (chronic obstructive pulmonary disease)[1][2].PF-03715455 is a moderate inhibitor of CYP1A2, CYP2C19, and CYP2D6 and a potent inhibitor of CYP’s 2C9 and CYP3A4[2].PF-03715455 treatment shows that the Vss and T1/2 are 0.19 L/kg, 1 hour, respectively[2]. Animal Model: Male CD Sprague Dawley rats (300-450 g)[2] Dosage: 1 mg/kg Administration: I.v. (Pharmacokinetic Analysis) Result: The Vss, and T1/2 were 0.19 L/kg, 1 hour, respectively.
More description
|
![]() |
DC10412 | AX20017 Featured |
AX20017 is a small-molecule protein kinase G (PknG) inhibitor with an IC50 of 0.39 μM.
More description
|
![]() |
DCAPI1343 | Amorolfine HCl Featured |
Amorolfine hydrochloride is a antifungal reagent.
More description
|
![]() |
DC10533 | PKM2 inhibitor(compound 3k) Featured |
A novle PKM2 inhibitor inhibitor.
More description
|
![]() |
DC10594 | Tolcide 2230 Featured |
An antimicrobial agent used as a substitute for chlorophenols
More description
|
![]() |
DC20341 | Ciliobrevin D Featured |
Ciliobrevin D is a cell-permeable, reversible, specific inhibitor of cytoplasmic dynein, blocks dynein-dependent microtubule gliding and ATPase activity while sparing kinesin dependent cellular trafficking.
More description
|
![]() |
DC32783 | BAM15 Featured |
BAM15 is a potent and selective mitochondrial uncoupler or protonophore. Chemical mitochondrial uncouplers are lipophilic weak acids that transport protons into the mitochondrial matrix via a pathway that is independent of ATP synthase, thereby uncoupling nutrient oxidation from ATP production. These uncouplers have potential for the treatment of diseases such as obesity, Parkinson’s disease, and aging.
More description
|
![]() |
DC12254 | UC-1728 Featured |
UC-1728 is a potent rabbit soluble epoxide hydrolase (sEH) inhibitor, with an IC50 of 2 nM on rabbit liver.
More description
|
![]() |
DC22569 | BTTAA Featured |
BTTAA is a Cu(I)-stabilizing ligand, whch performs potently with ubiquitin Glu18AzF.
More description
|
![]() |
DC31451 | CCS-1477(CBP-IN-1) Featured |
CCS-1477 is a potent and selective p300/CBP bromodomain inhibitor, is targeted & differentiated from BET inhibitors in prostate cancer cell lines in vitro. Combination of CCS1477 & JQ1 resulted in a highly synergistic inhibitory effect on proliferation in normal 22Rv1 cells. Global gene expression analysis revealed significantly fewer altered genes after CCS1477 (27 up, 119 down) compared to JQ1 (196 up, 655 down).
More description
|
![]() |